NCT02897700 2024-04-17
COC-IDCB
Shanghai Jiao Tong University School of Medicine
Phase 1 Recruiting
Clinical Trials
10 trialsNCT00486356 2024-01-03
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
Phase 1 Completed
NCT06121570 2023-11-08
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1 Recruiting
NCT01386346 2018-12-12
VEOX
Weill Medical College of Cornell University
Phase 1 Completed
NCT00822848 2018-09-07
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Phase 1 Completed
NCT00096304 2018-04-10
Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Medical University of South Carolina
Phase 1 Terminated
NCT00878904 2017-03-24
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
University of California, San Francisco
Phase 1 Completed
NCT00246103 2017-02-23
Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02392845 2015-03-19
MODEL1
Hospices Civils de Lyon
Phase 1 Completed
NCT00020748 2011-03-24
Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
Georgetown University
Phase 1 Completed